Effectiveness of Chinese herbal medicine combined with conventional medicine on acute exacerbation of chronic obstructive pulmonary disease: a systematic review and Meta-analysis

被引:0
作者
Guo, Wen [1 ]
Li, Xuanlin [1 ]
Zhao, Hulei [2 ]
Lei, Siyuan [1 ]
Xie, Yang [2 ]
Li, Jiansheng [1 ]
机构
[1] Henan Univ Chinese Med, Coconstruct Collaborat Innovat Ctr Resp Dis Diag &, Henan Key Lab Chinese Med Resp Dis, Zhengzhou 450046, Peoples R China
[2] Henan Univ Chinese Med, Affiliated Hosp 1, Dept Resp Dis, Zhengzhou 450000, Peoples R China
关键词
drugs; Chinese herbal; pulmonary disease; chronic obstructive; acute exacerbation; systematic review; Meta-analysis; GRADE approach; GLOBAL STRATEGY; COPD; PREVENTION; MANAGEMENT; DIAGNOSIS;
D O I
10.19852/j.cnki.jtcm.2023.02.003
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
OBJECTIVE: To systematically evaluate the efficacy and safety of Chinese herbal medicine (CHM) combined with conventional Western Medicine (CWM) on acute exacerbation of chronic obstructive pulmonary disease (AECOPD) based on high-quality randomized placebo -controlled trials.METHODS: We searched PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure Database, Chinese Biomedical Literature Database, China Science and Technology Journal Database, and Wanfang databases for randomized placebo-controlled trials of CHM treatment for AECOPD from inception to June 4, 2021. The Cochrane Collaboration's tool and the Grading of Recommendations, Assessment, Development and Evaluation were used to assess the risk of bias and the evidence quality of the included studies. Revman 5.3 software was used for Meta-analysis. RESULTS: A total of 9 trials involving 1591 patients were included. The Meta-analysis showed that based on CWM treatment, CHM group had significant advantages over the placebo group in ameliorating clinical total effective rate [RR = 1.29, 95% CI (1.07, 1.56), P = 0.007, low quality] and TCM symptom scores [MD =-2.99, 95% CI (-4.46,-1.53), P < 0.0001, moderate quality], improving arterial blood gas results [PaO2: MD = 4.51, 95% CI (1.97, 7.04), P = 0.0005, moderate quality; PaCO2: MD =-2.87, 95% CI (-4.28,-1.46), P < 0.0001, moderate quality], reducing CAT scores [MD =-2.08, 95% CI (-2.85,-1.31), P < 0.000 01, moderate quality],length of hospitalization [MD = -1.87, 95% CI ( -3.33, -0.42), P = 0.01, moderate quality], and acute exacerbation rate [RR = 0.60, 95% CI (0.43, 0.83), P = 0.002, moderate quality]. No serious CHM-related adverse events were reported.CONCLUSIONS: The current evidence indicates that CHM is an effective and well-tolerated adjunct therapy for AECOPD patients receiving CWM. However, considering the high heterogeneity, this conclusion requires confirmation.(c) 2023 JTCM. All rights reserved.
引用
收藏
页码:212 / 220
页数:9
相关论文
共 35 条
[1]   Management and prevention of exacerbations of COPD [J].
Aaron, Shawn D. .
BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[2]  
[Anonymous], 2002, Guiding Principles for Clinical Research of New Traditional Chinese Medicines (Trial)
[3]   Outcomes for COPD pharmacological trials:: from lung function to biomarkers [J].
Cazzola, M. ;
MacNee, W. ;
Martinez, F. J. ;
Rabe, K. F. ;
Franciosi, L. G. ;
Barnes, P. J. ;
Brusasco, V. ;
Burge, P. S. ;
Calverley, P. M. A. ;
Celli, B. R. ;
Jones, P. W. ;
Mahler, D. A. ;
Make, B. ;
Miravitlles, M. ;
Page, C. P. ;
Palange, P. ;
Parr, D. ;
Pistolesi, M. ;
Rennard, S. I. ;
Moelken, M. P. Rutten-Van ;
Stockley, R. ;
Sullivan, S. D. ;
Wedzicha, J. A. ;
Wouters, E. F. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (02) :416-468
[4]   Safety of Chinese Herbal Medicine for Chronic Obstructive Pulmonary Disease [J].
Coyle, Meaghan ;
Shergis, Johannah Linda ;
Liu, Shaonan ;
Wu, Lei ;
Zhang, Anthony Lin ;
Guo, Xinfeng ;
Lu, Chuanjian ;
Xue, Charlie Changli .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
[5]   Xiaoqinglong decoction (a traditional Chinese medicine) combined conventional treatment for acute exacerbation of chronic obstructive pulmonary disease A systematic review and meta-analysis [J].
Gao, Zhen ;
Jing, Jing ;
Liu, Yingying .
MEDICINE, 2020, 99 (14)
[6]  
Gerdesmeyer L, 2017, PAIN PHYSICIAN, V20, P387
[7]  
Global Initiative for Chronic Obstructive Lung Disease, 2021, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease
[8]  
Higgins JP, 2011, Cochrane handbook for systematic reviews of interventions
[9]  
Huang M. R., 2019, TRADITIONAL CHIN MED, V18, P40, DOI [10.14046/j.cnki.zyytb2002.2019., DOI 10.14046/J.CNKI.ZYYTB2002.2019]
[10]   Acute exacerbation of COPD [J].
Ko, Fanny W. ;
Chan, Ka Pang ;
Hui, David S. ;
Goddard, John R. ;
Shaw, Janet G. ;
Reid, David W. ;
Yang, Ian A. .
RESPIROLOGY, 2016, 21 (07) :1152-1165